Standard BioTools Inc. Money Market Funds, at Carrying Value
Standard BioTools Inc. (LAB) had Money Market Funds, at Carrying Value of $77.72 million as of 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Notes › Cash Equivalents, at Carrying Value
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2019-03-18
- 2018-12-31: Money Market Funds, at Carrying Value $77.72M.
- 2017-12-31: Money Market Funds, at Carrying Value $16.14M.
- 2016-12-31: Money Market Funds, at Carrying Value $21.06M.
- 2016-06-30: Money Market Funds, at Carrying Value $11.51M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2018-12-31 | $77.72M 10-K · filed 2019-03-18 |
| 2017-12-31 | $16.14M 10-K · filed 2019-03-18 |
| 2016-12-31 | $21.06M 10-K · filed 2018-03-08 |
| 2016-06-30 | $11.51M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $20.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $11.23M 10-K · filed 2017-03-03 |
| 2015-09-30 | $10.84M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $10.73M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $15.90M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $10.22M 10-K · filed 2016-02-29 |
| 2014-09-30 | $10.56M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $17.39M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $77.49M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $17.55M 10-K · filed 2015-02-26 |
| 2013-09-30 | $5.80M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $16.41M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $18.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $17.00K 10-K · filed 2014-03-12 |
| 2012-09-30 | $242.00K 10-Q · filed 2012-11-09 |
| 2011-12-31 | $1.80M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |